It is considered the most specific marker for CD4+/CD25+ and CD8+/CD25+ Treg lymphocytes, although its expression was also confirmed in tumor cells (Chaput et al. 2009; Takenaka et al. 2013). Here, CD4 is linked to neoplasm.